top of page

Clinical Proteomics Identifies XPNPEP3 in T2DM Fatty Liver

  • May 22
  • 0 min read
Clinical proteomics study design flowchart for plasma XPNPEP3
biomarker discovery in T2DM and MASLD patients.

 
 
logo02_edited.png

California NanoSystems Institute

570 Westwood Plaza
Bldg 114, Rm 6350H, Mail 722710
Los Angeles, California 90095‐7227

Copyright © 2026

Dalton Bioanalytics Inc.

Subscribe to Our Newsletter

Thanks for subscribe!

  • LinkedIn
  • X
  • cb
  • gs2
bottom of page